Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More

BACKGROUND: Corticosteroids use in severe coronavirus disease 2019 (COVID-19) improves survival; however, the optimal dose is not established. We aim to evaluate clinical outcomes in patients with severe COVID-19 receiving high-dose corticosteroids (HDC) versus low-dose corticosteroids (LDC). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Seema, Smith, Zachary, Soman, Sana, Jain, Saniya, Yako, Atheel, Hojeij, Marwa, Massoud, Louis, Alsaadi, Ayman, Williams, Jonathan, Kenney, Rachel, Miller, Joseph, Alangaden, George, Ramesh, Mayur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689728/
https://www.ncbi.nlm.nih.gov/pubmed/35024376
http://dx.doi.org/10.1093/ofid/ofab619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689728/
https://www.ncbi.nlm.nih.gov/pubmed/35024376
http://dx.doi.org/10.1093/ofid/ofab619

Ejemplares similares